Custom Radiolabeling of Synthetic Oligonucleotides
​
AM Chemicals offers services in expert synthesis of radiolabeled oligonucleotides and their phosphorothioate analogs (1 to 100 µmol of isolated product) including:
-
Synthesis of -labeled, protected nucleoside phosphoramidite building blocks
-
Synthesis of the target radiolabeled oligonucleotides
-
Purification by reverse-phase or ion-exchange HPLC as requested by customer and desalting
-
For siRNA, forming a duplex by hybridization with the unlabeled strand
-
Optionally, confirmation of structure by ES MS
-
Optionally, removal of endotoxin from the final product
-
Optionally, performing above operations under GMP conditions
Custom Quote
​
AM Chemicals is pleased to provide a custom quote for radiolabeled oligonucleotide synthesis project.
To request the custom quote, please furnish the following information:
-
Oligonucleotide sequence
-
Desired radioisotope ( )
-
Placement of the radiolabeled nucleoside in the sequence
-
Desired specific activity (SA):
-
A single labeling affords SA of 30-40, 100-400, and 500-1500 Ci/mol for radioisotopes, respectively
-
-
Desired amount of radiolabel incorporated or amount of radiolabeled oligonucleotide
-
Customers’ ability to provide project-specific unlabeled phosphoramidites of modified nucleosides or non-nucleosidic moieties
​
Guidelines for Optimal Cost Control of Radio-labeling Project
​
-
Awareness of radiolytic degradation saves money: aim for the specific activity of the target oligonucleotide as low as permissible
-
Use -thymidine or as carriers of the radiolabel
-
Placement of the radiolabeled moiety: close to the 5'-terminus of the target oligonucleotide
-
Provide project-specific unlabeled phosphoramidites of nucleosides or non-nucleosidic moieties
-
For shipping, solution is a preferred physical state of the finished product (oligo)
-
Acknowledge lead time for radio-labeling project (8 to 12 weeks) and plan ahead
